Contact this trialFirst, we need to learn more about you.
Angiotensin Receptor-Neprilysin Inhibitor
Sacubitril-Valsartan +1 More for Heart Failure
Recruiting5 awardsPhase 4
Cleveland, Ohio
This trial is testing a new heart medication in patients with a left ventricular assist device (LVAD). The goal is to see if the new drug is better tolerated and more effective than the current standard of care.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.